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Background and Aims: AIF (apoptosis inducing factor) is a flavin and NADH containing
protein located within mitochondria required for optimal function of the respiratory
chain. AIF may function as an antioxidant within mitochondria, yet when released from
mitochondria it activates caspase-independent cell death. The Harlequin (Hq) mouse has
a markedly reduced content of AIF, providing an experimental model to query if the
main role of AIF in the exacerbation of cell death is enhanced mitochondrial generation
of reactive oxygen species (ROS) or the activation of cell death programs. We asked
if the ROS generation is altered in Hq heart mitochondria at baseline or following
ischemia-reperfusion (IR).
Methods: Buffer perfused mouse hearts underwent 30min ischemia and 30min
reperfusion. Mitochondrial function including oxidative phosphorylation and H2O2
generation was measured. Immunoblotting was used to determine the contents of AIF
and PAR [poly(ADP-ribose)] in cell fractions.
Results: There were no differences in the release of H2O2 between wild type (WT) and
Hq heart mitochondria at baseline. IR increased H2O2 generation from WT but not from
Hq mitochondria compared to corresponding time controls. The complex I activity was
decreased in WT but not in Hq mice following IR. The relocation of AIF from mitochondria
to nucleus was increased in WT but not in Hq mice. IR activated PARP-1 only in WT mice.
Cell injury was decreased in the Hq mouse heart following in vitro IR.
Conclusion: A deficiency of AIF within mitochondria does not increase ROS production
during IR, indicating that AIF functions less as an antioxidant within mitochondria. The
decreased cardiac injury in Hq mouse heart accompanied by less AIF translocation to the
nucleus suggests that AIF relocation, rather than the AIF content within mitochondria,
contributes to cardiac injury during IR.
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INTRODUCTION
Apoptosis inducing factor (AIF) is a nuclear encoded protein syn-
thesized as a 67 kDa precursor (Sevrioukova, 2011; Natarajan and
Becker, 2012). The mature form of AIF (62 kDa) is located within
the mitochondrial intermembrane space following import and
removal of the mitochondrial localization signal (Sevrioukova,
2011; Natarajan and Becker, 2012). AIF has a pro-survival role
when it is located within mitochondria, whereas release of AIF
from mitochondria into cytosol followed by nuclear import
activates caspase-independent cell death (Sevrioukova, 2011;
Natarajan and Becker, 2012). The presence of FAD and NAD
cofactors in the mature AIF renders it a potential antioxidant
within the mitochondrial intermembrane space (Klein et al.,
2002; van Empel et al., 2005), although this concept has been
challenged (Sevrioukova, 2011). Nonetheless, the presence of
these cofactors strongly suggests that AIF responses both within
mitochondria and following release are likely responsive to and
modulated by the local redox environment (Sevrioukova, 2011).
The lower expression of AIF in Harlequin (Hq) mice impacts
metabolism and response to tissue stress, in an organ-dependent
manner (Klein et al., 2002; Vahsen et al., 2004). AIF deletion
is embryonic lethal (Klein et al., 2002). When activated follow-
ing birth, AIF deletion in heart and skeletal muscle leads to
profound dilated cardiomyopathy and muscle wasting due to a
marked decrease in electron transport complex I activity con-
comitant with increased reactive oxygen species (ROS) produc-
tion from mitochondria (Joza et al., 2005; Pospisilik et al., 2007).
Attenuation of the severity of AIF deficiency through extensive
backcross breeding or the use of (female) heterozygotes leads to
more modest defects in mitochondrial respiration that do not
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exhibit increased ROS production in the baseline state, and in fact
display potential resistance to exogenous disease (Pospisilik et al.,
2007) suggestive of protective modulation of metabolism (Chen
et al., 2007; Oxler et al., 2012). Thus, consistent with observa-
tions in other genetic models of partial complex I deficiency, a
protective response to tissue injury may be observed (Oxler et al.,
2012).
The Hq mouse exhibits an approximately 80% decrease in
AIF content in all tissues. Defects are most profound in brain,
with decreased complex I activity and complex I dependent res-
piration (Klein et al., 2002) and the development of disease in
retina and brain (Hisatomi et al., 2001), reminiscent of human
mitochondrial disease (Sevrioukova, 2011). In contrast, in heart,
the metabolic defects are more subtle, although increased car-
diac injury following in vivo ischemia-reperfusion (IR) and an
increased susceptibility to heart failure in an aortic banding
model of cardiac pressure overload have been reported (van
Empel et al., 2005). The capacity to scavenge ROS is reported to
be decreased in Hq mouse heart mitochondria compared to wild
type (van Empel et al., 2005), suggesting that AIF has a potential
antioxidant role. However, the net release of H2O2 is not altered
in Hq mouse brain mitochondria compared to wild type (Chinta
et al., 2009). This finding does not support an antioxidant role for
AIF within mitochondria.
Cardiac mitochondria provide the energy to support heart
function, whereas diseased and disabled mitochondria are
a source of cardiomyocyte damage (Lesnefsky et al., 2001;
Gustafsson and Gottlieb, 2008; Murphy and Steenbergen, 2008).
IR results in damage to the electron transport chain that serves
as a key source of ROS that exacerbate cardiac injury (Turrens,
2003; Chen et al., 2007). The net release of ROS from intact
mitochondria represents a balance between ROS generation and
the capacity of mitochondrial antioxidants (Turrens et al., 1991;
Rigobello et al., 2006; Wenzel et al., 2008; Stanley et al., 2011). In
the present study, we investigated if the net release of ROS from
Hqmouse heart mitochondria is increased compared to wild type
at baseline and if the genetic knockdown of AIF in Hqmice affects
the net ROS generation and susceptibility to injury in the heart
following the tissue stress of IR.
Translocation of AIF from mitochondria to the nucleus trig-
gers caspase-independent cell death by inducing DNA damage
(Yu et al., 2002; Sevrioukova, 2011; Natarajan and Becker, 2012).
The mature form of AIF is anchored in the inner mitochondrial
membrane (Ozaki et al., 2007; Chen et al., 2011). IR leads to a
release of AIF from mitochondria into cytosol in isolated mouse
heart, whereas administration of a calpain inhibitor prevents the
loss of AIF from mitochondria (Chen et al., 2011). These results
support that activation of mitochondrial localized µ-calpain is
required to detach the AIF from the innermembrane (Ozaki et al.,
2007; Chen et al., 2011) and indicate that retention of AIF within
mitochondria provides cardioprotection during IR (Chen et al.,
2011). The protection through retention of AIF within mitochon-
dria can be due to a potential antioxidant role of the AIF or the
prevention of AIF translocation to the nucleus. In the present
study, mitochondria and nucleus were isolated from buffer per-
fused hearts to evaluate if IR increases the AIF translocation from
mitochondria to nucleus. In the in vivo IR model, the length of
the ischemic period was limited in that a relative long ischemic
period could trigger a fatal arrhythmia occurrence in Hq mice
(van Empel et al., 2005). Thus, a buffer perfused heart model
was selected in the present study to avoid this confounding issue
and to allow an ischemic period resulting in a moderate extent
of mitochondrial and cardiac damage, relevant to in situ IR. Hq
mice provide an experimental model to test the potential contri-
bution of AIF to local mitochondrial protection compared to the
deleterious cellular effects of nuclear translocation during IR.
METHODS
The experimental procedures conformed to the Guide for the
Care and Use of Laboratory Animals and were approved by
the Institutional Animal Care and Use Committees of Virginia
Commonwealth University (VCU) and the McGuire Department
of Veterans Affairs Medical Center.
PREPARATION OF MOUSE HEART FOR PERFUSION
Wild type or Hq mice [2–3 months of age (22–28 g), male]
were anesthetized with pentobarbital sodium (100mg/g i.p.) and
anti-coagulated with heparin (1 IU/g i.p.) (Chen et al., 2011).
In this study, only male mice were used because Hq mice had
a gender-dependent response in an experimental stroke model
(Yuan et al., 2009). Compared to male Hq mice, female Hq
mice exhibited markedly decreased brain injury after experimen-
tal stroke (Yuan et al., 2009). Since the AIF gene is located on
the X chromosome, using male mice will avoid gender-dependent
gene dosage effects on cardioprotection. Hearts were excised and
retrograde perfused via the aorta in the Langendorff mode (con-
stant pressure, 75mmHg) with modified Krebs-Henseleit buffer
(composition, in mM: 115 NaCl, 4.0 KCl, 2.0 CaCl2, 25 NaHCO3,
1.1 MgSO4 · H2O, 0.9 KH2PO4, and 5.5 glucose) oxygenated
with 95% O2+5% CO2. Cardiac function was monitored with
a balloon inserted into the left ventricle using Powerlab (AD
Instruments, Colorado Springs, CO). Heart rate was maintained
at 420 bpm with pacing during the equilibration period. Pacing
was stopped during global ischemia and restored at 15min reper-
fusion. In the IR group, hearts were buffer-perfused for 15min,
followed by 30min global ischemia at 37◦C within 30min reper-
fusion (mitochondrial isolation) or 1 h reperfusion (infarction
measurement). In the time control group, hearts were buffer-
perfused without IR. Myocardial infarct size was determined
using TTC staining (Chen et al., 2006). Coronary effluent was
collected to determine LDH activity in each group (Chen et al.,
2006).
ISOLATION OF CARDIAC MITOCHONDRIA FROM THE MOUSE HEART
WITH PROTEASE
Trypsin was used in the mitochondrial isolation protocol in
order to remove potential contamination from AIF located in
the cytosol (Chen et al., 2011). The mouse heart was harvested
and immediately placed in cold buffer A [100mM KCl, 50mM
3-(N-morpholino) propanesulfonic acid (MOPS), 1mM EGTA,
5mMMgSO4, 1mMATP]. Cardiac tissue was homogenized with
a polytron at 10,000 rpm and incubated with trypsin (5mg/g) for
15min. Cold buffer B (0.2% BSA+ buffer A) was then added into
the homogenate. The homogenate was centrifuged at 500 × g for
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10min. The supernatant was centrifuged at 3000 × g for 10min.
to pellet mitochondria. The mitochondrial pellet was washed and
suspended in 100mM KCl, 50mMMOPS, and 0.5mM EGTA.
ISOLATION OF NUCLEUS FROM BUFFER-PERFUSED MOUSE HEARTS
The polytron pellet was used to isolate nuclear components
using a commercial kit from Thermo Scientific (Pittsburgh, PA,
catalog # 78835) using supplied solutions and differential cen-
trifugation according to instructions provided.
MEASUREMENT OF OXIDATIVE PHOSPHORYLATION AND ENZYME
ACTIVITIES IN ISOLATED MITOCHONDRIA
Oxygen consumption by mitochondria was measured using
a Clark-type oxygen electrode at 30◦C using glutamate
+ malate (complex I substrate) or succinate + rotenone
(complex II substrate) as donors (Lesnefsky et al., 1997).
Respiratory enzyme activities [NADH-decylubiquinol oxidore-
ductase, rotenone sensitive (complex I)]; NADH ferricyanide
oxioreductase (NFR, flavoprotein portion of complex I);
Succinate-decylubiquinone oxidoreductase (complex II); and cit-
rate synthase were measured in detergent solubilized mitochon-
dria according to the method of Dr. Hoppel as previously
described (Krahenbuhl et al., 1991; Lesnefsky et al., 1997; Chen
et al., 2008).
DETECTION OF H2O2 PRODUCTION FROM ISOLATED MOUSE HEART
MITOCHONDRIA
H2O2 production by isolated mitochondria was measured using
the oxidation of the fluorogenic indicator Amplex red in the pres-
ence of horseradish peroxidase without exogenous SOD (Chen
et al., 2003). Glutamate + malate and succinate + rotenone
were used as complex I and complex II substrates, respectively.
Rotenone and antimycin A were used to detect themaximal H2O2
generation from complex I and complex III, respectively.
DETERMINATION OF MITOCHONDRIAL CALCIUM RETENTION
CAPACITY
Mitochondrial calcium retention capacity (CRC) was used to
reflect opening of the mitochondrial permeability transition pore
(MPTP) in isolated mitochondria (Chen et al., 2012a). CRC was
studied in the single cell fluorimeter (PerkinElmer, Waltham,
Massachusetts) using repetitive calcium pulses (Chen et al.,
2012a). Freshly isolated mitochondria (0.25mg) were incubated
in buffer (150mM sucrose, 50mM KCl, 2mM KPi, and 20mM
Tris/HCl, pH 7.4) for 90 s with stirring at 30◦C with 0.5µM
calcium green. Succinate (5mM) was used as substrate. Pulses
of calcium (5 nmoles) were added at 60 s intervals. The number
of pulses that resulted in calcium release indicated the onset of
MPTP.
WESTERN BLOT ANALYSIS
Particle free cytosol, purified mitochondria, and nucleus were
boiled for 5min. in buffer including 4% (w/v) SDS, 1mM 2-
mercaptoethanol, 10mM Tris/HCl (pH 6.8) and 10% (w/v)
glycerol. Equal amounts of protein were loaded onto 4–15%
or 4–20% SDS-PAGE (dependent on molecular weight of pro-
teins), electrophoresed and transferred to a PVDF membrane.
The membranes were first blocked by 5% non-fat milk for 1 h fol-
lowed by exposure to primary antibodies overnight (Chen et al.,
2011). Antibodies to AIF, PARP-1, GAPDH, lamin, and subunit
IV of cytochrome oxidase were purchased from Cell Signaling
Technology (Danvers, MA). Monoclonal PAR antibody was pur-
chased from Millipore (Billerica, MA). The blots were incubated
with peroxidase conjugated anti-rabbit or anti-mouse secondary
antibody for 1 h prior to ECL detection (GE Healthcare Life
Science, Pittsburgh, PA). The intensity of blotting was quantified
by Fuji Film Image station (Edison, NJ).
STATISTICAL ANALYSIS
Data were expressed as the mean ± standard error of the mean.
Differences among four groups were compared by one-way anal-
ysis of variance with post-hoc comparisons performed using the
Student-Newman-Keuls test of multiple comparisons (Sigmastat
3.5, ProgramPaketet, Gothenburg, Sweden). Differences in CRC
and H2O2 between wild type and Hq mice were compared by
unpaired student t-test. A difference of p < 0.05 was considered
significant.
RESULTS
IR DECREASED OXIDATIVE PHOSPHORYLATION IN BOTH WILD TYPE
AND Hq HEART MITOCHONDRIA
There were no differences in the rate of oxidative phosphorylation
between time control wild type and Hq mitochondria when glu-
tamate + malate (complex I) or succinate + rotenone (complex
II) were used as substrates. IR decreased the ADP-stimulated res-
piration inmitochondria from both wild type andHq using either
substrate (Table 1). The rate of dinitrophenol (DNP) uncou-
pled respiration was also decreased in both wild type and Hq
mice following IR (Table 1), supporting that IR damages the
electron transport chain. Interestingly, the rate of oxidative phos-
phorylation with glutamate + malate in Hq hearts was decreased
following IR compared to corresponding wild type (Table 1),
whereas the rate of succinate oxidation was similar in Hq and wild
type hearts following IR (Table 1). These results indicated that
Table 1 | The rate of oxidative phosphorylation in wild type and Hq
mitochondria following IR.
Mice n State 3 State 4 RCR ADP/O DNP
GLUTAMATE + MALATE WAS USED AS COMPLEX I SUBSTRATE
(nAO/min/mg PROTEIN)
WT-TC N = 8 324±11 56±5 6.2±0.8 2.73±0.108 341±18
WT-IR N = 8 271±10* 56±4 5.1±0.5 2.80±0.09 281±11*
Hq-TC N = 6 315±27 51±9 6.7±0.8 2.80±0.08 321±40
Hq-IR N = 7 224±12*† 52±9 5.3±1.1 2.76±0.13 229±16*†
SUCCINATE + ROTENONE WAS USED AS COMPLEX II SUBSTRATE
(nAO/min/mg PROTEIN)
WT-TC N = 8 474±14 144±3 3.3±0.1 2.00±0.07 435±12
WT-IR N = 8 266±11* 133±6 2.0±0.1* 1.84±0.05 339±14*
Hq-TC N = 6 496±20 133±18 3.4±0.2 2.08±0.06 471±30
Hq-IR N = 7 268±15* 124±6 2.2±0.1* 2.07±0.09 346±25*
Mean ± s.e.m. *p < 0.05 vs. corresponding time control (TC); †p < 0.05
vs. WT-IR (ischemia-reperfusion). RCR, respiratory control ratio. DNP (0.3mM),
dinitrophenol to measure the rate of uncoupled respiration.
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IR led to additional decreases in respiration in Hq mouse heart
mitochondria when NADH-dependent substrates were used.
IR DECREASED COMPLEX I ACTIVITY IN WILD TYPE BUT NOT Hq
MOUSE HEART MITOCHONDRIA
In order to test if IR led to further damage to complex
I; NADH:decylubiquinol oxidoredutase, NFR, and complex II
activities were measured. Complex I activity [shown as the ratio
of complex I/CS (citrate synthase), Table 2] was decreased in wild
type following IR compared to time control. However, complex
I activity was not decreased in Hq mitochondria following IR
compared to its corresponding time control. The NADH dehy-
drogenase activity (NFR) was not decreased in either wild type or
Hq mice following IR (Table 2), consistent with previous study
(Chen et al., 2007; Szczepanek et al., 2011). NADH dehydroge-
nase activity was slightly higher in Hq mouse heart mitochondria
following IR compared to corresponding wild type (Table 2). The
physiological significance of this subtle difference is unclear. IR
did not alter complex II activity in wild type or Hqmice (Table 2).
These results support that IR leads to a complex I defect in wild
type mouse heart mitochondria.
THE GENERATION OF H2O2 WAS DECREASED IN Hq MOUSE HEART
MITOCHONDRIA FOLLOWING IR
There were no differences in H2O2 generation between time
control wild type and Hq heart mitochondria using complex I
(Figure 1A) or complex II substrates (Figure 1C). IR markedly
increased the production of H2O2 in wild type but not in Hq
mouse heart mitochondria with either a complex I or complex II
substrate (Figures 1A,C). Compared to time control, inhibition
of complex I using rotenone dramatically increased H2O2 gener-
ation in wild type mouse heart following IR (Figure 1B). In con-
trast, rotenone inhibition did not increase the H2O2 generation
in Hq mouse heart following IR (Figure 1B). The maximal ROS
generation from mitochondria was induced with antimycin A
inhibition. Inhibition of complex III using antimycin A increased
the H2O2 generation in both wild type and Hq mouse heart fol-
lowing IR vs. time control (Figure 1D). However, there were no
differences in ROS generation between wild type and Hq mice
with or without IR.
CARDIAC INJURY WAS DECREASED IN Hq MOUSE HEART FOLLOWING
IR
In the buffer perfused hearts, myocardial injury was decreased in
the Hq mouse heart following IR compared to wild type. Knock
down of AIF content in Hq mouse heart did not affect the cardiac
function before ischemia (Figure 2A). IR decreased left ventricu-
lar developed pressure (LVDP) in both wild type andHq hearts vs.
time control. Systolic function was improved in Hq hearts vs. wild
type during reperfusion (Figure 3A). Strikingly, the infarct size
was also much smaller in Hq mice than in wild type (Figure 2B).
The release of LDH into coronary effluent was much lower
in Hq mice than in wild type (Figure 2C), also indicating less
necrosis.
IR DECREASED THE CRC IN BOTH WILD TYPE AND Hq MOUSE HEART
MITOCHONDRIA
The CRC (Figure 3A) was decreased in mitochondria from non-
ischemic Hq mice compared to wild type (Figure 3B), suggesting
that a decrease in AIF content within mitochondria sensitizes to
calcium-stimulated MPTP opening. Although there was a slight
difference in the CRC between Hq and wild type following IR
(Figures 3A,B), the small magnitude of this difference may not
exert a significant impact on cardiac injury during IR.
IR ACTIVATED PARP-1 IN WILD TYPE BUT NOT IN Hq MICE
Activation of PARP-1 during IR increases the generation of PAR
[Poly (ADP-ribose) (PAR)] that is transferred to cytosol and
mitochondria (Sevrioukova, 2011). The content of PAR was
markedly increased in wild type following IR compared to time
control (Figures 4A–C), indicating that IR leads to PARP-1 acti-
vation. In contrast, IR did not alter the PAR content in Hq mice
following IR (Figures 4A–C).
IR DECREASED THE AIF CONTENT WITHIN MITOCHONDRIA AND
INCREASED NUCLEAR AIF CONTENT IN WILD TYPE MICE
The precursor of AIF (67 kd) is nuclear-encoded and subse-
quently transported into the mitochondrial matrix via its mito-
chondrial targeting sequence (Sevrioukova, 2011). The mature
form of AIF (62 kd) is formed in the matrix through cleav-
age of precursor protein via a mitochondrial matrix peptidase
(Sevrioukova, 2011). The mature AIF (62 kd) is transferred into
the mitochondrial intermembrane space through the Tim23 pro-
tein (Sevrioukova, 2011). Consistent with these concepts, two
AIF bands are detected in non-ischemic wild type mouse heart
mitochondria (Figure 4D). In contrast, the mature form of AIF
(62 kd) is almost undetectable in Hq mouse heart mitochon-
dria (Figure 4D), confirming the lower content of AIF within
mitochondria. The content of AIF within mitochondria was
decreased in wild type mice following IR compared to time
control (Figure 4D). The AIF content (62 kd) in nucleus was
increased in wild type hearts following IR (Figure 4E).
Table 2 | The enzyme activities of Complex I and II in wild type and Hq mitochondria with and without IR.
Mice n CS Complex I/CS NFR/CS CII/CS CII+Q/CS
WT-TC N = 8 2934±1.4 0.200±0.019 0.656±0.055 0.039±0.011 0.111± 0.020
WT-IR N = 8 2937±1.9 0.142±0.010* 0.542±0.029 0.059±0.008 0.142± 0.012
Hq-TC N = 6 2751±1.7 0.195±0.019 0.767±0.050 0.045±0.010 0.132± 0.026
Hq-IR N = 7 2545±1.7 0.174±0.019 0.793±0.081† 0.039±0.010 0.103± 0.027
Mean ± s.e.m. *p < 0.05 vs. WT-TC; †p < 0.05 vs. WT-IR. NFR, NADH dehydrogenase; CS, citrate synthase. Complex II activity (CII) was determined in the presence
and absence of exogenous decylubiquinone (Q).
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FIGURE 1 | Ischemia-reperfusion (IR) increases the net H2O2
production in wild type but not in Hq mouse cardiac mitochondria.
There were no differences in the net release of H2O2 between wild type
and Harlequin mouse heart mitochondria from non-ischemic hearts. IR
increased the generation of H2O2 in wild type but not in Harlequin mice
compared to time control (A). The maximal H2O2 generation from
complex I was measured using rotenone to inhibit complex I. An AIF
deficiency in Harlequin mice did not alter the maximal H2O2 generation
from complex I compared to wild type in control heart (B). The maximal
H2O2 generation from complex I was also decreased in Harlequin mice
following IR compared to wild type (B). Knock down of AIF in Harlequin
mice did not alter the H2O2 generation using succinate + rotenone as
complex II substrates compared to wild type control. The H2O2
generation was decreased in Harlequin mice following IR compared to
wild type (C). The maximal H2O2 generation from complex III in the
presence of antimycin A was not decreased in Harlequin mice following
IR compared to wild type (D). Data are expressed as mean ± s.e.m.;
∗p < 0.05 vs. time control; †p < 0.05 vs. wild type IR.
DISCUSSION
In the present study, a deficiency of AIF within Hq mouse heart
mitochondria does not increase the net release of H2O2 compared
to wild type, consistent with reports in brain mitochondria. IR
leads to increased net release of ROS from wild type heart mito-
chondria compared to non-ischemic controls. In contrast, the net
release of ROS from Hq heart mitochondria is unchanged fol-
lowing IR. Thus, genetic knockdown of AIF within mitochondria
does not increase the net release of ROS from the electron trans-
port chain. These findings suggest that AIF less likely functions
as a key mitochondrial antioxidant in the heart, especially follow-
ing the stress of IR. The PARP-1 is activated in wild type but not
in Hq mice following IR. Translocation of the AIF from mito-
chondria to the nucleus is increased in wild type but not in Hq
mice following IR. The decrease in cardiac injury in Hq mouse
heart accompanied by less AIF translocation to the nucleus sug-
gests that the amount of AIF that relocates to the nucleus, rather
than the AIF content within mitochondria, is the key factor that
contributes to cardiac injury during IR.
COMPLEX I DAMAGE DURING IR
Complex I activity is decreased in heart mitochondria follow-
ing both in vivo (Rouslin and Millard, 1980; Rouslin, 1983) and
in vitro IR (Lesnefsky et al., 2001; Gustafsson and Gottlieb, 2008;
Murphy and Steenbergen, 2008). In the present study, IR leads to
decreased complex I activity without alteration in NADH dehy-
drogenase activity (NFR). These results indicate that ischemia
likely damages complex I at the iron sulfur centers (Chen et al.,
2008) distal to the flavoprotein, in line with previous studies
(Ohnishi and Trumpower, 1980; Chen et al., 2006; Zhou et al.,
2006; Szczepanek et al., 2011).
Oxidative modification of complex I by nitrosation (Burwell
et al., 2006) or glutathionylation (Hurd et al., 2008) or the mod-
ification of its inner membrane environment via depletion of
cardiolipin (Paradies et al., 2004) all contribute to decreases in
activity. Mitochondrial AIF content also affects complex I activ-
ity, especially in brain and retina (Klein et al., 2002; van Empel
et al., 2005). Depletion of AIF also decreases complex I activity in
heart mitochondria (Pospisilik et al., 2007). However, the effect of
lower expression of AIF in Hq mice on heart mitochondrial com-
plex I activity is not consistent (Szczepanek et al., 2013). Thus, an
AIF deficiency may affect complex I activity in a tissue-dependent
manner. Genetic depletion of PARP-1 protects complex I activ-
ity in mouse heart following IR (Zhou et al., 2006), indicating
that PARP-1 activation contributes to the complex I defect during
IR. In the present study, IR decreases complex I activity accom-
panied by an activated PARP-1 in wild type mice. In contrast,
IR does not decrease complex I activity in Hq mice. PARP-1 is
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FIGURE 2 | IR led to decreased cardiac injury in Harlequin mice
compared to wild type. Heart rate was maintained at 420 bpm by pacing
during 15min equilibration perfusion. The pacing was stopped during
ischemia and resumed at 15min reperfusion. The recovery of myocardial
contractile function during reperfusion, shown by the improvement in left
ventricular developed pressure (LVDP mmHg, A), was improved in
Harlequin mice compared to wild type. The diastolic function was also
improved in Harlequin mice following IR, reflected by a decrease in left
ventricular end-diastolic pressure (LVEDP) at the end of reperfusion (B). The
cardiac injury during IR was decreased in Harlequin mice as shown by a
smaller infarct size (C) and less LDH release into coronary effluent. Data
are expressed as mean ± s.e.m.; ∗p < 0.05 vs. time control (TC); †p < 0.05
vs. wild type untreated IR.
also not activated in Hq mice following IR. These results support
that activation of PARP-1 contributes to the complex I defect dur-
ing IR. Since PARP-1 is considered as a nuclear protein, complex
I inhibition by PARP-1 activation appears to present a challenge
(Figure 5) (Zhou et al., 2006). Recently, a mitochondrial localized
PARP-1 has been identified (Rossi et al., 2009). Thus, activation
of PARP-1 may directly regulate complex I activity (Figure 5).
COMPLEX I INHIBITION AND CARDIOPROTECTION DURING IR
The ischemia-damaged respiratory chain including complex I, is
a key source of ROS that increases cardiac injury (Turrens, 2003;
Chen et al., 2007). Blockade of proximal electron transport using
amobarbital before ischemia protects complex I and decreases
cardiac injury during reperfusion, supporting that preservation
of complex I activity reduces cardiac injury (Chen et al., 2006).
Transient partial (Xu et al., 2014) or complete (Stewart et al.,
2009; Chen et al., 2012b) blockade of complex I at the onset of
reperfusion decreases myocardial injury in buffer perfused hearts,
indicating that a temporary complex I inhibition is also benefi-
cial for cardiac recovery. However, persistent, severe complex I
FIGURE 3 | IR decreased the CRC in wild type and Harlequin cardiac
mitochondria. Original tracings of CRC measurement in wild type heart
mitochondria were shown in panel (A). The CRC was decreased in control
Harlequin mouse heart mitochondria compared to wild type (B), suggesting
that the sensitivity to MPTP opening was increased in Harlequin mice in the
basal condition. IR led to decreased CRC in both wild type and Harlequin
mice compared to time control (B). Compared to wild type, IR led to a
slight further decrease in CRC in Harlequin mice (B). Data are expressed as
mean ± s.e.m.; ∗p < 0.05 vs. time control; †p < 0.05 vs. wild type IR.
inhibition is detrimental to the heart both at baseline and for
recovery during reperfusion (Karamanlidis et al., 2013). In con-
trast to wild type, the complex I activity is not altered in Hq mice
following IR. The lack of damage to complex I during IR in Hq
mice may lead to decreased ROS generation that contributes to
the observed decrease in cardiac injury in Hq mice. Alteration
of mitochondrial antioxidants including thioredoxin reductase-
2 significantly affects a release of H2O2 from mitochondria. The
IR-induced complex I damage may also increase H2O2 by inhibit-
ing thioredoxin reductase-2 through alteration of its redox state
(Rigobello et al., 2006; Horstkotte et al., 2011; Stanley et al., 2011).
The increased oxidative stress will favor activated µ-calpain to
cleave AIF and facilitate its release from mitochondria (Norberg
et al., 2010).
TRANSLOCATION OF AIF FROMMITOCHONDRIA TO NUCLEUS
INCREASES CARDIAC INJURY DURING IR
The mature form of AIF (62 kd) is anchored at the inner mito-
chondrial membrane within the intermembrane space (Otera
et al., 2005). Release of AIF from the mitochondria and translo-
cation to the nucleus to activate caspase-independent cell death
is a multistep process. First, the mature AIF bound within mito-
chondria on the inner membrane requires liberation. Cleavage of
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FIGURE 4 | IR increases AIF translocation from mitochondria to nucleus
in wild type. The content of poly (ADP-ribose) (PAR) was markedly increased
in wild type mice following IR compared to time control, indicating that IR
activated PARP-1 (A–C). There were no differences in the PAR content in Hq
mice between time control and mice following IR (A–C). GAPDH was used
as a cytosol marker for loading control. The precursor form of AIF (67 kd) and
the mature form of AIF (62 kd) were detected in wild type mouse heart
mitochondria (D). Compared to control, IR markedly decreased the content of
the mature form of AIF (62 kd band) in wild type mice (D). The mature AIF
content in Harlequin mice was of course decreased compared to wild type
(D). In wild type, IR increased AIF content (62 kd) in nucleus compared to
time control, indicating a translocation of AIF from mitochondria to nucleus
(E). Subunit 4 of cytochrome oxidase and lamin were used as protein loading
control for mitochondria and nucleus, respectively.
the mature 62 kd form of AIF by activated mitochondrial calpains
(Ozaki et al., 2007), t-bid (Cabon et al., 2012) or other proteases
can liberate AIF from the inner membrane, with release of a trun-
cated, approximately 57 kd AIF peptide. Next, permeation of the
outer mitochondrial membrane is required for AIF release (Ozaki
et al., 2007). IR increases MPTP opening as a mechanism of
increased outer membrane permeability (Weiss et al., 2003), with
oxidative stress is a key contributor to the increased susceptibility
to MPTP opening during IR (Weiss et al., 2003; Halestrap et al.,
2004; Chen et al., 2012a). In contrast, activation of PARP-1 is not
involved in the permeation of the outer mitochondrial membrane
during IR (Schriewer et al., 2013). The decreased AIF content in
the purifiedmitochondria following IR supports that IR does lead
to a loss of AIF from mitochondria. The increased MPTP open-
ing in wild type mice during reperfusion favors a release of AIF
from mitochondria into cytosol with subsequent translocation
to the nucleus. It currently appears that even following MPTP,
the released AIF is the 57 kd cleaved form, at least based upon
calcium activation of mitochondrial calpains concomitant with
MPTP. This area of calciummediated injury deserves further con-
sideration. As discussed above, IR activates PARP-1 in wild type
but not Hq mice (Pacher and Szabo, 2007). Although activation
of PARP-1 provides a beneficial effect to repair DNA damage, over
activation of PARP-1 has a detrimental effect via consumption of
NAD+ (Pacher and Szabo, 2007). PAR, which is generated by acti-
vation of PARP-1 within nucleus, is released into cytosol and sub-
sequently relocates to mitochondria to induce AIF release from
mitochondria (Pacher and Szabo, 2007). Interestingly, a portion
of the mature AIF is also reported to be loosely attached on the
mitochondrial outer membrane (Yu et al., 2006, 2009). The PAR
can detach the AIF from the outer membrane (Figure 5) (Wang
et al., 2009). Outer membrane bound-AIF has been identified
in mouse heart mitochondria (Chen and Lesnefsky, unpublished
data). Thus, activation of PARP-1 may increase AIF transloca-
tion to the nucleus through detachment of mature AIF from the
outer membrane, in addition to release of the pool from the inner
membrane via cleavage. The accumulation of AIF in the nucleus
accompanied by increased cardiac injury in wild typemice follow-
ing IR supports the proposal that the translocation of AIF from
the mitochondria to the nucleus augments cardiac injury.
GENETIC INHIBITION OF AIF EXPRESSION IN Hq MICE DECREASES
CARDIAC INJURY DURING IR
Although cardiac injury is increased in Hq mouse heart follow-
ing in vivo IR compared to wild type controls (van Empel et al.,
2005), cardiac injury is actually decreased in Hq mouse heart
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FIGURE 5 | Depiction of the PARP-1 activation and AIF translocation
during IR. IR damages the electron transport chain and increases the ROS
generation from complex I and complex III and activates mitochondrial
µ-calpain (M-µ-Cal) to induce release of AIF from the inner mitochondrial
membrane. Translocation of AIF from mitochondria to nucleus enhances
DNA damage and PARP-1 activation, in turn further reducing NAD+ content.
Oxidative stress during IR leads to DNA damage DNA that activates the
PARP-1 that leads to decreased NAD+ content in cytosol and increased
generation of PAR within nucleus. The PAR is released into cytosol and
relocates to mitochondria and facilitates AIF release from the outer
mitochondrial membrane. The activated PARP-1 may contribute to complex
I defect through an indirect mechanism. IR may activate mitochondrial
localized PARP-1 to induce direct complex I damage in cardiac mitochondria.
CI, complex I; CIII, complex III; M-µ-Cal, mitochondrial µ-calpain.
following in vitro IR. Several key differences likely contribute
to these divergent results. In the present study, only male Hq
mice were used based upon the rationale discussed in Methods,
whereas both female and male Hq mice were included in the
previous in vivo study (van Empel et al., 2005). This is impor-
tant, since gender-related cardiac protection as well as gene dosage
issues related to the X chromosome location of the aif gene can
introduce variability. In the present study, only 2–3-month-old
mice were used whereas middle-aged and elderly mice were used
in the in vivo study (van Empel et al., 2005). In vivo, there is the
additional impact of exogenous inflammatory cells (with or with-
out AIF deficiency). Furthermore, in vivo, substrate utilization is
uncontrolled. The metabolism of fatty acids in vivo, in contrast
to glucose utilization in the current study, may have exacerbated
the phenotype of mitochondrial defects present. Taken together,
gender, age, exogenous cells and the different IR models likely
resulted in the differences observed in our current study com-
pared to the previous in vivo study. An isolated heart was used in
order to focus on myocyte specific responses in the present study.
In summary, the key contribution of AIF to cardiac injury
during IR is related to release from mitochondria and activa-
tion of programmed cell death via cytosolic transport, nuclear
import and DNA cleavage. The findings in cardiac mitochondria
from Hq mice compared to littermate controls support that a
decreased content of AIF does not enhance ROS production from
mitochondria nor augment cardiac injury at baseline nor during
IR. Thus, AIF does not exert significant mitochondrial antioxi-
dant protection during IR. The prevention of AIF translocation
to nucleus is a potentially powerful approach to reduce cardiac
injury.
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